nodes	percent_of_prediction	percent_of_DWPC	metapath
Hydrocodone—OPRM1—nicotine dependence	0.883	1	CbGaD
Hydrocodone—Dysphoria—Varenicline—nicotine dependence	0.007	0.0834	CcSEcCtD
Hydrocodone—Night sweats—Varenicline—nicotine dependence	0.00561	0.0668	CcSEcCtD
Hydrocodone—Gastrooesophageal reflux disease—Varenicline—nicotine dependence	0.00335	0.0399	CcSEcCtD
Hydrocodone—Musculoskeletal pain—Varenicline—nicotine dependence	0.00307	0.0365	CcSEcCtD
Hydrocodone—Deafness—Varenicline—nicotine dependence	0.00246	0.0293	CcSEcCtD
Hydrocodone—Hot flush—Varenicline—nicotine dependence	0.00235	0.028	CcSEcCtD
Hydrocodone—Menopausal symptoms—Varenicline—nicotine dependence	0.00233	0.0278	CcSEcCtD
Hydrocodone—Lethargy—Varenicline—nicotine dependence	0.00224	0.0267	CcSEcCtD
Hydrocodone—Osteoarthritis—Varenicline—nicotine dependence	0.0022	0.0262	CcSEcCtD
Hydrocodone—Migraine—Varenicline—nicotine dependence	0.00216	0.0258	CcSEcCtD
Hydrocodone—Affect lability—Varenicline—nicotine dependence	0.00216	0.0258	CcSEcCtD
Hydrocodone—Urinary retention—Varenicline—nicotine dependence	0.00209	0.0249	CcSEcCtD
Hydrocodone—Mood swings—Varenicline—nicotine dependence	0.00208	0.0248	CcSEcCtD
Hydrocodone—Hypokalaemia—Varenicline—nicotine dependence	0.002	0.0238	CcSEcCtD
Hydrocodone—Abdominal discomfort—Varenicline—nicotine dependence	0.00182	0.0217	CcSEcCtD
Hydrocodone—CYP2D6—CYP2E1 reactions—CYP2A7—nicotine dependence	0.00165	0.0824	CbGpPWpGaD
Hydrocodone—Galantamine—CHRNB3—nicotine dependence	0.00152	0.12	CrCbGaD
Hydrocodone—Oedema peripheral—Varenicline—nicotine dependence	0.0015	0.0178	CcSEcCtD
Hydrocodone—Connective tissue disorder—Varenicline—nicotine dependence	0.00149	0.0178	CcSEcCtD
Hydrocodone—Angiopathy—Varenicline—nicotine dependence	0.00138	0.0164	CcSEcCtD
Hydrocodone—Mediastinal disorder—Varenicline—nicotine dependence	0.00137	0.0163	CcSEcCtD
Hydrocodone—Mental disorder—Varenicline—nicotine dependence	0.00133	0.0159	CcSEcCtD
Hydrocodone—Malnutrition—Varenicline—nicotine dependence	0.00132	0.0158	CcSEcCtD
Hydrocodone—CYP2D6—Fatty acids—CYP2A7—nicotine dependence	0.00128	0.0643	CbGpPWpGaD
Hydrocodone—Back pain—Varenicline—nicotine dependence	0.00128	0.0153	CcSEcCtD
Hydrocodone—Muscle spasms—Varenicline—nicotine dependence	0.00127	0.0152	CcSEcCtD
Hydrocodone—Tremor—Varenicline—nicotine dependence	0.00124	0.0148	CcSEcCtD
Hydrocodone—Cough—Varenicline—nicotine dependence	0.00116	0.0138	CcSEcCtD
Hydrocodone—Galantamine—CHRNA6—nicotine dependence	0.00115	0.0906	CrCbGaD
Hydrocodone—Convulsion—Varenicline—nicotine dependence	0.00115	0.0137	CcSEcCtD
Hydrocodone—Myalgia—Varenicline—nicotine dependence	0.00113	0.0134	CcSEcCtD
Hydrocodone—Arthralgia—Varenicline—nicotine dependence	0.00113	0.0134	CcSEcCtD
Hydrocodone—Anxiety—Varenicline—nicotine dependence	0.00112	0.0134	CcSEcCtD
Hydrocodone—Unspecified disorder of skin and subcutaneous tissue—Varenicline—nicotine dependence	0.00112	0.0133	CcSEcCtD
Hydrocodone—Dry mouth—Varenicline—nicotine dependence	0.0011	0.0131	CcSEcCtD
Hydrocodone—Nervous system disorder—Varenicline—nicotine dependence	0.00106	0.0126	CcSEcCtD
Hydrocodone—Thrombocytopenia—Varenicline—nicotine dependence	0.00106	0.0126	CcSEcCtD
Hydrocodone—Skin disorder—Varenicline—nicotine dependence	0.00105	0.0125	CcSEcCtD
Hydrocodone—Hyperhidrosis—Varenicline—nicotine dependence	0.00104	0.0124	CcSEcCtD
Hydrocodone—CYP2D6—Xenobiotics—CYP2A7—nicotine dependence	0.00102	0.0511	CbGpPWpGaD
Hydrocodone—Hypotension—Varenicline—nicotine dependence	0.00101	0.012	CcSEcCtD
Hydrocodone—Musculoskeletal discomfort—Varenicline—nicotine dependence	0.000985	0.0117	CcSEcCtD
Hydrocodone—Galantamine—CHRNA5—nicotine dependence	0.000981	0.077	CrCbGaD
Hydrocodone—Insomnia—Varenicline—nicotine dependence	0.000977	0.0116	CcSEcCtD
Hydrocodone—Dyspnoea—Varenicline—nicotine dependence	0.000963	0.0115	CcSEcCtD
Hydrocodone—Somnolence—Varenicline—nicotine dependence	0.000961	0.0114	CcSEcCtD
Hydrocodone—Gastrointestinal disorder—Varenicline—nicotine dependence	0.000933	0.0111	CcSEcCtD
Hydrocodone—Fatigue—Varenicline—nicotine dependence	0.000932	0.0111	CcSEcCtD
Hydrocodone—Constipation—Varenicline—nicotine dependence	0.000924	0.011	CcSEcCtD
Hydrocodone—Galantamine—CHRNA10—nicotine dependence	0.000923	0.0724	CrCbGaD
Hydrocodone—Gastrointestinal pain—Varenicline—nicotine dependence	0.000884	0.0105	CcSEcCtD
Hydrocodone—Abdominal pain—Varenicline—nicotine dependence	0.000854	0.0102	CcSEcCtD
Hydrocodone—Body temperature increased—Varenicline—nicotine dependence	0.000854	0.0102	CcSEcCtD
Hydrocodone—Hypersensitivity—Varenicline—nicotine dependence	0.000796	0.00948	CcSEcCtD
Hydrocodone—Asthenia—Varenicline—nicotine dependence	0.000775	0.00924	CcSEcCtD
Hydrocodone—Pruritus—Varenicline—nicotine dependence	0.000765	0.00911	CcSEcCtD
Hydrocodone—OPRD1—Peptide GPCRs—OPRM1—nicotine dependence	0.000715	0.0358	CbGpPWpGaD
Hydrocodone—Dizziness—Varenicline—nicotine dependence	0.000715	0.00851	CcSEcCtD
Hydrocodone—Vomiting—Varenicline—nicotine dependence	0.000687	0.00818	CcSEcCtD
Hydrocodone—Rash—Varenicline—nicotine dependence	0.000681	0.00812	CcSEcCtD
Hydrocodone—Dermatitis—Varenicline—nicotine dependence	0.000681	0.00811	CcSEcCtD
Hydrocodone—Headache—Varenicline—nicotine dependence	0.000677	0.00806	CcSEcCtD
Hydrocodone—OPRD1—G alpha (i) signalling events—TAS2R16—nicotine dependence	0.000673	0.0337	CbGpPWpGaD
Hydrocodone—CYP3A4—Xenobiotics—CYP2A7—nicotine dependence	0.000667	0.0334	CbGpPWpGaD
Hydrocodone—Galantamine—CHRNB4—nicotine dependence	0.000663	0.052	CrCbGaD
Hydrocodone—Nausea—Varenicline—nicotine dependence	0.000642	0.00765	CcSEcCtD
Hydrocodone—OPRK1—Peptide GPCRs—OPRM1—nicotine dependence	0.000627	0.0314	CbGpPWpGaD
Hydrocodone—Galantamine—CHRNB2—nicotine dependence	0.000606	0.0476	CrCbGaD
Hydrocodone—OPRK1—G alpha (i) signalling events—TAS2R16—nicotine dependence	0.00059	0.0296	CbGpPWpGaD
Hydrocodone—Heroin—OPRM1—nicotine dependence	0.000569	0.0447	CrCbGaD
Hydrocodone—Methylnaltrexone—OPRM1—nicotine dependence	0.000507	0.0398	CrCbGaD
Hydrocodone—OPRM1—G alpha (i) signalling events—TAS2R16—nicotine dependence	0.000499	0.025	CbGpPWpGaD
Hydrocodone—Dextromethorphan—CHRNB4—nicotine dependence	0.000496	0.0389	CrCbGaD
Hydrocodone—Galantamine—CHRNA3—nicotine dependence	0.000459	0.0361	CrCbGaD
Hydrocodone—Dextromethorphan—CHRNB2—nicotine dependence	0.000454	0.0356	CrCbGaD
Hydrocodone—Levorphanol—OPRM1—nicotine dependence	0.000447	0.0351	CrCbGaD
Hydrocodone—Dihydrocodeine—OPRM1—nicotine dependence	0.000431	0.0339	CrCbGaD
Hydrocodone—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.000423	0.0212	CbGpPWpGaD
Hydrocodone—CYP2D6—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.000418	0.0209	CbGpPWpGaD
Hydrocodone—OPRD1—GPCR ligand binding—TAS2R16—nicotine dependence	0.000407	0.0204	CbGpPWpGaD
Hydrocodone—Oxymorphone—OPRM1—nicotine dependence	0.000378	0.0297	CrCbGaD
Hydrocodone—Naltrexone—OPRM1—nicotine dependence	0.000378	0.0297	CrCbGaD
Hydrocodone—Ethylmorphine—OPRM1—nicotine dependence	0.000361	0.0284	CrCbGaD
Hydrocodone—OPRK1—GPCR ligand binding—TAS2R16—nicotine dependence	0.000357	0.0179	CbGpPWpGaD
Hydrocodone—Dextromethorphan—CHRNA3—nicotine dependence	0.000344	0.027	CrCbGaD
Hydrocodone—CYP2D6—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.000343	0.0172	CbGpPWpGaD
Hydrocodone—OPRD1—Peptide ligand-binding receptors—OPRM1—nicotine dependence	0.000336	0.0168	CbGpPWpGaD
Hydrocodone—OPRM1—GPCR ligand binding—TAS2R16—nicotine dependence	0.000302	0.0151	CbGpPWpGaD
Hydrocodone—Oxycodone—OPRM1—nicotine dependence	0.000302	0.0237	CrCbGaD
Hydrocodone—OPRK1—Peptide ligand-binding receptors—OPRM1—nicotine dependence	0.000295	0.0148	CbGpPWpGaD
Hydrocodone—Codeine—OPRM1—nicotine dependence	0.000288	0.0226	CrCbGaD
Hydrocodone—Galantamine—CHRNA4—nicotine dependence	0.000284	0.0223	CrCbGaD
Hydrocodone—OPRD1—G alpha (i) signalling events—OPRM1—nicotine dependence	0.000284	0.0142	CbGpPWpGaD
Hydrocodone—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.000277	0.0139	CbGpPWpGaD
Hydrocodone—Naloxone—OPRM1—nicotine dependence	0.000276	0.0217	CrCbGaD
Hydrocodone—Hydromorphone—OPRM1—nicotine dependence	0.000274	0.0215	CrCbGaD
Hydrocodone—CYP3A4—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.000273	0.0137	CbGpPWpGaD
Hydrocodone—OPRD1—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.000263	0.0132	CbGpPWpGaD
Hydrocodone—OPRK1—G alpha (i) signalling events—OPRM1—nicotine dependence	0.000249	0.0125	CbGpPWpGaD
Hydrocodone—Morphine—OPRM1—nicotine dependence	0.000233	0.0183	CrCbGaD
Hydrocodone—OPRK1—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.000231	0.0116	CbGpPWpGaD
Hydrocodone—OPRD1—GPCR downstream signaling—TAS2R16—nicotine dependence	0.00023	0.0115	CbGpPWpGaD
Hydrocodone—OPRD1—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.000226	0.0113	CbGpPWpGaD
Hydrocodone—CYP3A4—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.000224	0.0112	CbGpPWpGaD
Hydrocodone—Dextromethorphan—CHRNA4—nicotine dependence	0.000213	0.0167	CrCbGaD
Hydrocodone—OPRD1—Signaling by GPCR—TAS2R16—nicotine dependence	0.000209	0.0105	CbGpPWpGaD
Hydrocodone—OPRD1—G alpha (i) signalling events—DRD2—nicotine dependence	0.000205	0.0103	CbGpPWpGaD
Hydrocodone—OPRK1—GPCR downstream signaling—TAS2R16—nicotine dependence	0.000202	0.0101	CbGpPWpGaD
Hydrocodone—OPRK1—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.000198	0.00991	CbGpPWpGaD
Hydrocodone—Dextromethorphan—OPRM1—nicotine dependence	0.000196	0.0154	CrCbGaD
Hydrocodone—CYP2D6—Metapathway biotransformation—AKR1B10—nicotine dependence	0.000193	0.00969	CbGpPWpGaD
Hydrocodone—OPRD1—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.00019	0.00953	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling by GPCR—TAS2R16—nicotine dependence	0.000183	0.00918	CbGpPWpGaD
Hydrocodone—CYP2D6—Biological oxidations—CYP2A7—nicotine dependence	0.000182	0.00913	CbGpPWpGaD
Hydrocodone—OPRD1—GPCR downstream signaling—FGD1—nicotine dependence	0.000181	0.00905	CbGpPWpGaD
Hydrocodone—CYP2D6—Metapathway biotransformation—CYP2A7—nicotine dependence	0.00018	0.00901	CbGpPWpGaD
Hydrocodone—OPRK1—G alpha (i) signalling events—DRD2—nicotine dependence	0.00018	0.00901	CbGpPWpGaD
Hydrocodone—OPRD1—GPCR ligand binding—OPRM1—nicotine dependence	0.000172	0.0086	CbGpPWpGaD
Hydrocodone—OPRM1—GPCR downstream signaling—TAS2R16—nicotine dependence	0.000171	0.00855	CbGpPWpGaD
Hydrocodone—OPRK1—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000167	0.00836	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling by GPCR—FGD1—nicotine dependence	0.000164	0.00822	CbGpPWpGaD
Hydrocodone—OPRD1—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000163	0.00817	CbGpPWpGaD
Hydrocodone—OPRK1—GPCR downstream signaling—FGD1—nicotine dependence	0.000158	0.00794	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling by GPCR—TAS2R16—nicotine dependence	0.000155	0.00776	CbGpPWpGaD
Hydrocodone—OPRM1—G alpha (i) signalling events—DRD2—nicotine dependence	0.000152	0.00761	CbGpPWpGaD
Hydrocodone—OPRK1—GPCR ligand binding—OPRM1—nicotine dependence	0.000151	0.00754	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling by GPCR—FGD1—nicotine dependence	0.000144	0.00721	CbGpPWpGaD
Hydrocodone—OPRK1—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000143	0.00716	CbGpPWpGaD
Hydrocodone—OPRM1—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000141	0.00706	CbGpPWpGaD
Hydrocodone—OPRM1—GPCR downstream signaling—FGD1—nicotine dependence	0.000134	0.00671	CbGpPWpGaD
Hydrocodone—CYP3A4—Metapathway biotransformation—AKR1B10—nicotine dependence	0.000126	0.00633	CbGpPWpGaD
Hydrocodone—OPRD1—GPCR ligand binding—DRD2—nicotine dependence	0.000124	0.00622	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—TAS2R16—nicotine dependence	0.000124	0.00619	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling by GPCR—FGD1—nicotine dependence	0.000122	0.00609	CbGpPWpGaD
Hydrocodone—OPRM1—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000121	0.00605	CbGpPWpGaD
Hydrocodone—CYP3A4—Biological oxidations—CYP2A7—nicotine dependence	0.000119	0.00597	CbGpPWpGaD
Hydrocodone—CYP3A4—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000118	0.00589	CbGpPWpGaD
Hydrocodone—OPRK1—GPCR ligand binding—DRD2—nicotine dependence	0.000109	0.00545	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—TAS2R16—nicotine dependence	0.000108	0.00542	CbGpPWpGaD
Hydrocodone—OPRD1—GPCR downstream signaling—OPRM1—nicotine dependence	9.71e-05	0.00486	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—FGD1—nicotine dependence	9.69e-05	0.00485	CbGpPWpGaD
Hydrocodone—OPRM1—GPCR ligand binding—DRD2—nicotine dependence	9.2e-05	0.00461	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—TAS2R16—nicotine dependence	9.15e-05	0.00458	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling by GPCR—OPRM1—nicotine dependence	8.81e-05	0.00441	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—AKR1B10—nicotine dependence	8.56e-05	0.00429	CbGpPWpGaD
Hydrocodone—OPRK1—GPCR downstream signaling—OPRM1—nicotine dependence	8.51e-05	0.00426	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—FGD1—nicotine dependence	8.5e-05	0.00426	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling by GPCR—OPRM1—nicotine dependence	7.73e-05	0.00387	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—AKR1B10—nicotine dependence	7.51e-05	0.00376	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—FGD1—nicotine dependence	7.18e-05	0.0036	CbGpPWpGaD
Hydrocodone—OPRD1—GPCR downstream signaling—DRD2—nicotine dependence	7.02e-05	0.00351	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling by GPCR—DRD2—nicotine dependence	6.37e-05	0.00319	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—AKR1B10—nicotine dependence	6.34e-05	0.00318	CbGpPWpGaD
Hydrocodone—OPRK1—GPCR downstream signaling—DRD2—nicotine dependence	6.15e-05	0.00308	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—WASF2—nicotine dependence	6.03e-05	0.00302	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—WASF1—nicotine dependence	5.78e-05	0.0029	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling by GPCR—DRD2—nicotine dependence	5.59e-05	0.0028	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—WASF2—nicotine dependence	5.29e-05	0.00265	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—OPRM1—nicotine dependence	5.21e-05	0.00261	CbGpPWpGaD
Hydrocodone—OPRM1—GPCR downstream signaling—DRD2—nicotine dependence	5.2e-05	0.0026	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—WASF1—nicotine dependence	5.07e-05	0.00254	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling by GPCR—DRD2—nicotine dependence	4.72e-05	0.00237	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—OPRM1—nicotine dependence	4.57e-05	0.00229	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—WASF2—nicotine dependence	4.47e-05	0.00224	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—WASF1—nicotine dependence	4.29e-05	0.00215	CbGpPWpGaD
Hydrocodone—OPRD1—Signaling Pathways—DRD2—nicotine dependence	3.76e-05	0.00189	CbGpPWpGaD
Hydrocodone—OPRK1—Signaling Pathways—DRD2—nicotine dependence	3.3e-05	0.00165	CbGpPWpGaD
Hydrocodone—CYP2D6—Metabolism—CYP2A7—nicotine dependence	3.12e-05	0.00156	CbGpPWpGaD
Hydrocodone—OPRM1—Signaling Pathways—DRD2—nicotine dependence	2.79e-05	0.0014	CbGpPWpGaD
Hydrocodone—CYP3A4—Metabolism—CYP2A7—nicotine dependence	2.04e-05	0.00102	CbGpPWpGaD
